408 related articles for article (PubMed ID: 15756580)
21. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
[TBL] [Abstract][Full Text] [Related]
22. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy.
Bandello F; Pognuz DR; Pirracchio A; Polito A
Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):1024-7. PubMed ID: 15064955
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
Karacorlu M; Mudun B; Ozdemir H; Karacorlu SA; Burumcek E
Am J Ophthalmol; 2004 Aug; 138(2):289-91. PubMed ID: 15289142
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.
Al-Haddad CE; Jurdi FA; Bashshur ZF
Am J Ophthalmol; 2004 Jun; 137(6):1151-3. PubMed ID: 15183815
[TBL] [Abstract][Full Text] [Related]
29. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
[TBL] [Abstract][Full Text] [Related]
30. Combined intravitreal bevacizumab and triamcinolone acetonide injection for idiopathic neuroretinitis.
Cakir M; Cekiç O; Bozkurt E; Pekel G; Yazici AT; Yilmaz OF
Ocul Immunol Inflamm; 2009; 17(3):221-3. PubMed ID: 19585368
[TBL] [Abstract][Full Text] [Related]
31. Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study.
Brasil OF; Smith SD; Galor A; Lowder CY; Sears JE; Kaiser PK
Br J Ophthalmol; 2007 Jun; 91(6):761-5. PubMed ID: 17108013
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma.
Shields CL; Demirci H; Dai V; Marr BP; Mashayekhi A; Materin MA; Manquez ME; Shields JA
Retina; 2005; 25(7):868-74. PubMed ID: 16205566
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
[TBL] [Abstract][Full Text] [Related]
34. Intravitreal triamcinolone acetonide for choroidal granuloma in sarcoidosis.
Chan WM; Lim E; Liu DT; Law RW; Lam DS
Am J Ophthalmol; 2005 Jun; 139(6):1116-8. PubMed ID: 15953451
[TBL] [Abstract][Full Text] [Related]
35. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
36. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.
Krebs I; Binder S; Stolba U
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):863-7. PubMed ID: 16331486
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
38. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
Er H; Yilmaz H
Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
[TBL] [Abstract][Full Text] [Related]
39. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study.
Koutsandrea C; Moschos MM; Brouzas D; Loukianou E; Apostolopoulos M; Moschos M
Retina; 2007 Feb; 27(2):159-64. PubMed ID: 17290196
[TBL] [Abstract][Full Text] [Related]
40. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
